1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Global Markets for Catheters

Global Markets for Catheters

  • May 2016
  • -
  • BCC Research
  • -
  • 177 pages

This BCC Research report studies the present status of the worldwide catheter market and evaluates its potential over the five-year period from 2016 to 2021.

Use this report to:

Determine the present status of the worldwide catheter market and to evaluate its potential over the five-year period from 2016 to 2021.
Understand the current catheter market scenario for five major application segments:cardiovascular, urological, neurovascular, intravenous and specialty catheters.
Assess the growth and market potential of catheters for the completion of cardiovascular surgery and neurosurgery.
Analyze the current catheter market for the projections of worldwide, geographic and type of product market revenues, new applications and products, and future catheter sales.

Highlights

The global catheter market has grown to $24.9 billion in 2016 from $23.9 billion in 2015. The market is expected to grow at a five-year compound annual growth rate (CAGR) of 4.7% from 2016 to 2021, reaching nearly $31.3 billion by 2021.

The cardiovascular catheter market is expected to grow from $11.7 billion in 2016 to $14.8billion in 2021, increasing at a CAGR of 4.8% for the period 2016-2021.

The global market for neurovascular catheters is expected to grow from $513.3 million in 2016 to $824.6 million in 2021, increasing at a CAGR of 9.9% for the period 2016-2021.

STUDY GOALS AND OBJECTIVES

BCC Research’s goal in conducting this study was to determine the present status of the worldwide catheter market and to evaluate its potential over the five-year period from 2016 to 2021. An assessment of the worldwide catheter market was performed while considering five of its important segments: cardiovascular, urological, neurovascular, intravenous and specialty catheters.

REASONS FOR DOING THE STUDY

The market for catheters has expanded as interventional and less invasive procedures have become more popular. Catheters are vital to the completion of many procedures, and some procedures or interventions, particularly in cardiovascular surgery and neurosurgery, could not be done without the use of catheters. In conducting this study, BCC Research was interested in determining the areas of catheter applications poised
for growth and the reasons for their growth. New products and their future impact on the market were also assessed.

SCOPE OF REPORT

BCC Research analyzed the current catheter market based on (1) projections of worldwide, geographic and type of product market revenues through 2021, (2) on current and historical usage, (3) geographical and socio/economic market trends and (4) new applications and products.

The scope of this study encompasses the five major application segments of the catheter market. BCC Research analyzed each type of catheter segment, determined its current market status and examined its impact on future catheter sales. After this analysis, growth forecasts between 2016 and 2021 were projected. Catheter material analysis, regulatory issues and the latest technological trends are also covered.

Other influential factors such as patents and company profiles are discussed. Unless otherwise noted, all revenue values are in U.S. dollars at the time the research was conducted and are not adjusted for inflation.

The reviewed products in the report are not exhaustive and a number of products have been in the market for years.

Table Of Contents

Global Markets for Catheters
GLOBAL MARKETS FOR CATHETERS
HLC019G
May 2016
Melissa Elder
Project Analyst
ISBN: 1-62296-279-6
BCC Research
49 Walnut Park, Building 2
Wellesley, MA 02481 USA
866-285-7215 (toll-free within the USA),
or (+1) 781-489-7301
TABLE OF CONTENTS
TOPIC PAGE NO.
CHAPTER 1 INTRODUCTION 2
STUDY GOALS AND OBJECTIVES 2
REASONS FOR DOING THE STUDY 2
SCOPE OF REPORT 2
METHODOLOGY 2
INTENDED AUDIENCE 3
INFORMATION SOURCES 3
ANALYST'S CREDENTIALS 3
RELATED BCC RESEARCH REPORTS 3
BCC RESEARCH WEBSITE 4
DISCLAIMER 4
CHAPTER 2 SUMMARY 6
SUMMARY TABLE GLOBAL MARKET FOR CATHETERS BY SEGMENT, THROUGH 2021
($ MILLIONS) 7
SUMMARY FIGURE GLOBAL MARKET FOR CATHETERS BY SEGMENT, 2014-2021 ($
MILLIONS) 7
CHAPTER 3 OVERVIEW OF GLOBAL CATHETER INDUSTRY 9
DEFINITION 9
CATHETER DEVELOPMENT 9
CATHETER CONSTRUCTION 9
CATHETER APPLICATIONS 10
TYPES OF CATHETERS 10
CARDIOVASCULAR CATHETERS 10
Diagnostic Use of Cardiovascular Catheters 11
Therapeutic Use of Cardiovascular Catheters 11
TABLE 1 INDICATIONS FOR CARDIAC CATHETERIZATION 11
TABLE 2 TYPES OF CARDIAC CATHETERS 12
Angiography Catheters 12
Angiographic Catheter Features 12
Electrophysiology (EP) Catheters 13
Cardiac Ablation Catheters 13
Percutaneous Coronary Intervention (PCI) Catheters 13
PCI and Stent Placement 14
TABLE 3 PCI PROCEDURES 14
Rapid Exchange Balloon Catheters 15
Over-the-Wire PCI Catheters 15
Guiding Catheters 15
Possible Complications 15
UROLOGICAL CATHETERS 15
Possible Complications from Urological Catheter Use 16
Intermittent Catheters 16
Possible Complications of Intermittent Catheters 17
Indwelling Catheterization 17
Possible Complications from Indwelling Catheters 17
HLC019G - Global Markets for Catheters

TOPIC PAGE NO.
Suprapubic Catheterization 18
Male External Condom Catheterization 18
INTRAVENOUS (IV) CATHETERS 19
Single-Lumen Catheters 19
Multi-Lumen Catheter 19
SPECIALTY IV CATHETERS 19
PICC 19
Advantages of PICC Lines 20
Disadvantages of PICC Lines 20
CVC 20
CVC Catheter Placement 20
Advantages to Central Venous Catheters 21
Possible Complications Due to IV Catheters 21
TABLE 4 COMPLICATIONS DUE TO IV CATHETERS 21
Dialysis Catheters 22
NEUROVASCULAR CATHETERS 22
SPECIALTY CATHETERS 23
Anesthesia Catheters 23
Thermodilution Catheters 23
Suction Catheters 23
Oximetry Catheters 24
Reproductive Catheters 24
Rectal Catheters 25
Cholangiography Catheters 25
END-USER PREFERENCES 25
CATHETER SIZE 25
MATERIAL USED 26
COATING 26
LENGTH OF TIME CATHETER IS IN THE BODY 26
INFECTION RATE 26
COST 27
CHAPTER 4 CATHETERS AND INDUSTRY DRIVERS/RESTRAINTS 29
OVERVIEW 29
FIGURE 1 FACTORS INFLUENCING THE MEDICAL DEVICE MARKET 29
MARKET DRIVERS 29
WORLDWIDE ECONOMIC DEMOGRAPHICS 30
TABLE 5 HEALTHCARE EXPENDITURE AS A PERCENTAGE OF GDP BY COUNTRY,
2008-2014* (%) 30
WORLDWIDE POPULATION GROWTH 31
TABLE 6 LIFE EXPECTANCY DATA AND PROJECTIONS, 1970-2015 32
TABLE 7 ESTIMATES OF THE TOP 10 COUNTRIES WITH HIGHEST LIFE EXPECTANCY
AT AGE 65, 2015 (%) 32
TABLE 8 BIRTH RATES FOR SELECTED COUNTRIES, 2014 (%) 33
DEMOGRAPHIC TRENDS 33
GLOBALLY AGING POPULATION 33
TABLE 9 PERCENTAGE OF POPULATION AGE 65 AND OLDER IN SELECTED
COUNTRIES, 2014 (MILLIONS/%) 34

WESTERNIZATION OF DIETARY HABITS AND URBANIZATION 34
GROWING AFFLUENCE IN MIDDLE- AND LOWER-INCOME COUNTRIES 34
USE OF CATHETERS WORLDWIDE 35
CORONARY PROCEDURES 35
TABLE 10 NUMBER OF CORONARY ANGIOPLASTY PROCEDURES BY SELECTED
COUNTRY, 2005-2015* (PER 100,000 POPULATIONS) 35
CANCER 36
TABLE 11 PREVALENCE OF CANCER BY SELECTED COUNTRY, 2012* (PER 100,000
POPULATION) 36
MARKET RESTRAINTS 37
PCI VERSUS CABG 37
COMBINED THERAPIES 37
CATHETER REUSE 38
PRODUCT DISTRIBUTION 38
REIMBURSEMENT AND REGULATION TRENDS 38
GLOBAL FINANCIAL CONDITIONS 38
THIRD PARTY COVERAGE AND REIMBURSEMENT 39
GLOBAL COST CONTAINMENT 39
CHAPTER 5 CATHETER MATERIALS 41
INTRODUCTION 41
TABLE 12 CHARACTERISTICS OF CATHETER MATERIALS 41
KEY CHARACTERISTICS 41
SURFACE CHARACTERISTICS 42
CATHETERS USED IN ADVANCED IMAGING 42
MRA 42
OCT 42
RADIOPACITY IN CATHETERS 43
Determining Appropriate Properties of Radiopaque Catheters 43
Economics of Radiopacity 44
COMPONENT MATERIALS 44
LATEX 44
Latex Allergic Reactions 44
SILICONE 45
Silicone Catheter Characteristics 45
Disadvantage of Silicone Catheters 45
Cost Considerations for Silicone Catheters 45
POLYTETRAFLUOROETHYLENE (PTFE) 46
Uses 46
Cost Considerations 46
POLYURETHANE (PU) 46
Uses 46
Cost Considerations 47
POLYVINYL CHLORIDE (PVC) 47
Uses 47
Cost Considerations 47
POLYETHYLENE 47
Uses 47

Cost Considerations 47
CATHETER COATINGS 47
SILICONE ELASTOMER 48
HYDROPHILIC COATING 48
ANTIMICROBIAL COATING 48
Combating UTI 48
Combining Hydrophilic and Antimicrobial Coatings 48
Silver Coating 49
ADVANTAGES AND DISADVANTAGES OF CATHETER MATERIALS 49
TABLE 13 ADVANTAGES AND DISADVANTAGES OF CATHETER MATERIALS 49
CHAPTER 6 ANALYSIS OF THE GLOBAL CATHETER MARKET 52
GLOBAL CATHETER REVENUE ANALYSIS 52
TABLE 14 GLOBAL MARKET FOR CATHETERS BY TYPE, THROUGH 2021 ($ MILLIONS) 52
FIGURE 2 GLOBAL MARKET FOR CATHETERS BY TYPE, 2014-2021 ($ MILLIONS) 52
GLOBAL MARKET SHARE FORECAST BY TYPE OF CATHETER 53
FIGURE 3 GLOBAL MARKET SHARES OF CATHETERS BY TYPE, 2015 AND 2021 (%) 54
CARDIOVASCULAR CATHETERS 54
KEY MARKET CHALLENGES 55
Pharmacological Approaches Could Threaten Future Catheter
Demand 55
Limited Clinical Data and Outcomes Statistics 55
KEY MARKET DRIVERS FOR THE CARDIOVASCULAR SEGMENT 55
Increases in the Incidence of Cardiovascular Diseases 55
Popularity of Angioplasty and Stent Placement over CABG 56
Angiography is among the Leading Diagnostic Procedures for CVD 56
Effectiveness of Interventional Cardiac Procedures Compared with
Pharmaceutical-Based Therapies 57
KEY MARKET RESTRAINTS IN THE CARDIOVASCULAR MARKET 57
Constant Price Erosion 57
Decrease in Restenosis 57
Low Reimbursement Rates 57
Catheter Use in Conjunction with Stent Placement 58
CARDIOVASCULAR CATHETER REVENUE ANALYSIS 58
TABLE 15 GLOBAL MARKET FOR CARDIOVASCULAR CATHETERS BY TYPE,
THROUGH 2021 ($ MILLIONS) 59
FIGURE 4 GLOBAL MARKET FOR CARDIOVASCULAR CATHETERS BY TYPE,
2014-2021 ($ MILLIONS) 59
Angiography 60
Balloon Catheters 60
EP Catheters 61
TABLE 16 GLOBAL MARKET FOR EP CARDIOVASCULAR CATHETERS BY USE,
THROUGH 2021 ($ MILLIONS) 61
FIGURE 5 GLOBAL MARKET SHARES OF EP CARDIOVASCULAR CATHETERS BY USE,
2015 (%) 61
Guiding Catheters 62
Intravascular Ultrasound Catheters (IVUS) 62
MARKET SHARES BY COMPANY 62

FIGURE 6 GLOBAL MANUFACTURER MARKET SHARES OF ALL TYPES OF CARDIAC
CATHETERS, 2015 (%) 63
UROLOGICAL CATHETERS 64
MARKET CHALLENGES 64
Infection Rates 64
MARKET DRIVERS 64
Global Aging of the Population 64
Reimbursement 65
Growth in Male External Catheters 66
UROLOGICAL CATHETER REVENUE ANALYSIS 66
TABLE 17 GLOBAL MARKET FOR UROLOGICAL CATHETERS BY TYPE, THROUGH
2021 ($ MILLIONS) 67
FIGURE 7 GLOBAL MARKET FOR UROLOGICAL CATHETERS BY TYPE, 2014-2021 ($
MILLIONS) 67
Intermittent Catheter Revenues 67
TABLE 18 GLOBAL MARKET FOR INTERMITTENT UROLOGICAL CATHETERS BY USE,
THROUGH 2021 ($ MILLIONS) 68
FIGURE 8 GLOBAL MARKET SHARES OF INTERMITTENT UROLOGICAL CATHETERS
BY USE, 2015 (%) 68
Indwelling Catheter Revenues 69
MARKET SHARES BY COMPANY 69
FIGURE 9 GLOBAL MARKET SHARES OF UROLOGICAL CATHETERS BY COMPANY,
2015 (%) 70
INTRAVENOUS CATHETERS 70
MARKET CHALLENGES 70
Healthcare-Acquired Infections and Catheters 70
Surface-Modified Catheters 71
Catheter-Related Bloodstream Infections (CRBSIs) 71
MARKET DRIVERS 72
Increasing Number of End-Stage Renal Disease Populations 72
Aging Populations 72
GLOBAL INTRAVENOUS CATHETER MARKET 73
TABLE 19 GLOBAL MARKET FOR INTRAVENOUS CATHETERS BY TYPE, THROUGH
2021 ($ MILLIONS) 73
FIGURE 10 GLOBAL MARKET FOR INTRAVENOUS CATHETERS BY TYPE, 2014-2021
($ MILLIONS) 73
Central Venous Catheters 74
Dialysis Catheters 74
TABLE 20 GLOBAL MARKET FOR CENTRAL VENOUS CATHETERS BY USE, THROUGH
2021 ($ MILLIONS) 74
FIGURE 11 GLOBAL MARKET SHARES OF CENTRAL VENOUS CATHETERS BY USE,
2015 (%) 74
Peripheral Catheters 75
Peripherally Inserted Central Venous Catheters 75
MARKET SHARES BY COMPANY 75
FIGURE 12 GLOBAL MARKET SHARES OF IV CATHETERS BY COMPANY, 2015 (%) 76
NEUROVASCULAR CATHETERS 77
KEY MARKET CHALLENGES 77
Cost of Neurovascular Catheters 77

Availability of Pharmacological Treatment Options 78
Shortage of Qualified Professionals to Perform Surgeries 78
KEY MARKET DRIVERS 78
Enhanced Diagnostic and Imaging Technologies 78
Stenting and Aneurysm Treatments 78
New Catheter Technologies 78
Expanding Market for Unmet Treatment Options 79
NEUROVASCULAR CATHETER REVENUE ANALYSIS 79
TABLE 21 GLOBAL MARKET FOR NEUROVASCULAR CATHETERS, THROUGH 2021 ($
MILLIONS) 79
FIGURE 13 GLOBAL MARKET FOR NEUROVASCULAR CATHETERS, 2014-2021 ($
MILLIONS) 79
MARKET SHARES BY COMPANY 80
FIGURE 14 GLOBAL MARKET SHARES OF NEUROVASCULAR CATHETERS BY
COMPANY, 2015 (%) 80
SPECIALTY CATHETER MARKET 81
KEY MARKET DRIVERS 81
Demand for Enhanced Monitoring Devices 81
Effectiveness of Specialty Catheters in Surgical Applications 82
Aging Populations 82
Steady Assisted Reproductive Technology Use 82
KEY MARKET RESTRAINTS 82
Increased Cost 82
Introduction of Competing Technologies 82
Use of Thrombolytic Drugs 82
Embarrassment 83
SPECIALTY CATHETER MARKET REVENUE ANALYSIS 83
TABLE 22 GLOBAL MARKET FOR SPECIALTY CATHETERS BY TYPE, THROUGH 2021
($ MILLIONS) 83
FIGURE 15 GLOBAL MARKET FOR SPECIALTY CATHETERS BY TYPE, 2014-2021 ($
MILLIONS) 84
FIGURE 16 GLOBAL MARKET SHARES OF SPECIALTY CATHETERS BY TYPE, 2015 (%) 84
MARKET SHARES BY COMPANY 85
FIGURE 17 GLOBAL MARKET SHARES OF SPECIALTY CATHETERS BY COMPANY,
2015 (%) 86
GLOBAL CATHETER MARKET BY REGION 86
TABLE 23 GLOBAL MARKET FOR CATHETERS BY REGION, THROUGH 2021 ($
MILLIONS) 87
UNITED STATES 87
EUROPE 87
ASIA 87
REST OF WORLD 87
FIGURE 18 GLOBAL MARKET SHARES OF CATHETERS BY REGION, 2015 AND 2021
(%) 88
MARKET CONCLUSIONS 88
RESTRAINTS 89
Price Erosion Due to Fierce Competition is Decreasing Revenue
Potential 89
Longer Approval Times Are Delaying New Product Launches 89

Reimbursement Issues Have Affected the Use of Technologically
Advanced Catheters 89
Experienced Physicians Are Often Reluctant to Accept New Device
Technologies 89
DRIVERS 90
Increase in Minimally Invasive Procedures Has Led to Increased
Demand for Catheters 90
Increased Demand for Disposable Catheters 90
New Technologies in Catheter Design Have Increased Catheter Use 90
Advances in Imaging Technology Have Led to New Applications
Requiring the Use of Catheters 90
CHAPTER 7 U.S. CATHETER MARKET 92
SUMMARY 92
REVENUE ANALYSIS OF THE U.S. CATHETER MARKET 92
TABLE 24 U.S. MARKET FOR CATHETERS BY TYPE, THROUGH 2021 ($ MILLIONS) 92
FIGURE 19 U.S. MARKET FOR CATHETERS BY TYPE, 2014-2021 ($ MILLIONS) 92
TABLE 25 U.S. RATES OF CARDIOVASCULAR PROCEDURES, 2007-2010
(THOUSANDS) 94
TRENDS IN PROCEDURE USAGE 94
UROLOGICAL CATHETERS OVERVIEW 94
INTRAVENOUS CATHETERS OVERVIEW 95
NEUROVASCULAR CATHETERS OVERVIEW 96
SPECIALTY CATHETERS OVERVIEW 96
CHAPTER 8 EUROPEAN CATHETER MARKET 98
SUMMARY 98
CAUSES OF MORTALITY IN EU COUNTRIES 98
FIGURE 20 LEADING CAUSES OF DEATH FOR MEN AND WOMEN UNDER THE AGE
OF 75 IN THE EU (%) 98
WESTERN EUROPEAN HEALTHCARE SYSTEMS 99
EASTERN EUROPEAN HEALTHCARE SYSTEMS 99
GOVERNMENT REGULATION 100
EUROPEAN UNION REGULATION 100
RUSSIAN HEALTHCARE SYSTEM REGULATION 100
ECONOMIC CONDITIONS 100
REVENUE ANALYSIS OF THE EUROPEAN MARKET FOR CATHETERS 100
TABLE 26 EUROPEAN MARKET FOR CATHETERS BY TYPE, THROUGH 2021 ($
MILLIONS) 101
FIGURE 21 EUROPEAN MARKET FOR CATHETERS BY TYPE, 2014-2021 ($ MILLIONS) 101
CARDIOVASCULAR MARKET OVERVIEW 102
UROLOGICAL CATHETER MARKET OVERVIEW 102
INTRAVENOUS CATHETER OVERVIEW 102
NEUROVASCULAR CATHETER OVERVIEW 103
SPECIALTY CATHETER OVERVIEW 103
CHAPTER 9 ASIAN CATHETER MARKET 105
SUMMARY 105
AUSTRALIAN HEALTHCARE MARKET 105

Health Insurance in Australia 105
JAPANESE HEALTHCARE MARKET 106
INDIAN HEALTHCARE MARKET 106
Medical Insurance in India 106
CHINESE HEALTHCARE MARKET 106
Medical Device Regulations in China 107
Chinese Healthcare Institutions 107
Rural and Urban Healthcare Services 107
REVENUE ANALYSIS OF THE ASIAN MARKET FOR CATHETERS 108
TABLE 27 ASIAN MARKET FOR CATHETERS BY TYPE, THROUGH 2021 ($ MILLIONS) 108
FIGURE 22 ASIAN MARKET FOR CATHETERS BY TYPE, 2014-2021 ($ MILLIONS) 108
CARDIOVASCULAR MARKET OVERVIEW 109
UROLOGICAL CATHETER MARKET OVERVIEW 109
INTRAVENOUS CATHETER MARKET OVERVIEW 109
NEUROVASCULAR CATHETER MARKET OVERVIEW 110
SPECIALTY CATHETER MARKET OVERVIEW 110
CHAPTER 10 PATENT ANALYSIS 112
OVERVIEW 112
CATHETER INNOVATION 112
DEVELOPMENT OF A "SMART" CATHETER 112
SANOVAS SURGICAL TECHNOLOGIES 112
CATHETER PATENT ACTIVITY BY ASSIGNEE 113
TABLE 28 USPTO CATHETER PATENT ACTIVITY BY ASSIGNEE, LAST 100 PATENTS
THROUGH FEBRUARY 2016 (NO.) 113
USPTO CATHETER PATENTS BY YEAR 114
TABLE 29 USPTO CATHETER PATENTS ISSUED BY YEAR, 2005-2015 (NO.) 114
FIGURE 23 USPTO CATHETER PATENTS ISSUED BY YEAR, 2005-2015 (NO.) 114
USPTO CATHETER PATENTS BY TYPE 115
TABLE 30 USPTO CATHETER PATENTS ISSUED BY TYPE, 2015 (NO.) 115
FIGURE 24 USPTO CATHETER PATENTS ISSUED BY TYPE, 2015 (NO.) 116
CATHETER PATENT INFORMATION 116
TABLE 31 RECENT CATHETER PATENTS, DECEMBER 2015 116
CHAPTER 11 COMPANY PROFILES 134
LEADING MANUFACTURERS 134
TABLE 32 GLOBAL CATHETER MARKET SHARES OF LEADING MANUFACTURERS,
2015 (%) 134
MERGERS/ACQUISITIONS IN THE CATHETER MARKET 135
TABLE 33 MERGERS/ACQUISITIONS IN THE GLOBAL CATHETER MARKET, 2010-2015 135
ABBOTT LABORATORIES 136
BUSINESS OVERVIEW 136
PRODUCTS 136
TABLE 34 ABBOTT LABORATORIES CATHETER PRODUCTS 136
FINANCIAL SUMMARY 136
TABLE 35 ABBOTT LABORATORIES FINANCIAL SUMMARY, 2013-2015* 137
ANGIODYNAMICS 137
BUSINESS OVERVIEW 137
HLC019G - Global Markets for Catheters

PRODUCTS 137
TABLE 36 ANGIODYNAMICS CATHETER PRODUCTS 137
FINANCIAL SUMMARY 138
TABLE 37 ANGIODYNAMICS FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 138
ARGON MEDICAL DEVICES INC. 138
BUSINESS OVERVIEW 139
PRODUCTS 139
TABLE 38 ARGON MEDICAL CATHETER PRODUCTS 139
RECENT ACTIVITY 139
B. BRAUN MELSUNGEN AG 139
BUSINESS OVERVIEW 139
PRODUCTS 140
TABLE 39 B. BRAUN CATHETER PRODUCTS 140
FINANCIAL SUMMARY 141
TABLE 40 B. BRAUN FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 141
BECTON, DICKINSON AND CO. 141
BUSINESS OVERVIEW 141
PRODUCTS 142
TABLE 41 BECTON DICKINSON CATHETER PRODUCTS 142
FINANCIAL SUMMARY 142
TABLE 42 BECTON DICKINSON FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 142
RECENT ACTIVITY 143
BOSTON SCIENTIFIC CORP. 143
BUSINESS OVERVIEW 143
PRODUCTS 143
TABLE 43 BOSTON SCIENTIFIC CATHETER PRODUCTS 143
FINANCIAL SUMMARY 145
TABLE 44 BOSTON SCIENTIFIC FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 146
RECENT ACTIVITY 146
CARDINAL HEALTH 146
BUSINESS OVERVIEW 146
PRODUCTS 146
TABLE 45 CARDINAL HEALTH (CORDIS) CATHETER PRODUCTS 147
FINANCIAL SUMMARY 147
TABLE 46 CARDINAL HEALTH FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 147
RECENT ACTIVITY 148
CARDIOMED SUPPLIES INC. 148
BUSINESS OVERVIEW 148
PRODUCTS 148
TABLE 47 CARDIOMED CATHETER PRODUCTS 148
CODMAN NEURO (DEPUY) 149
BUSINESS OVERVIEW 149
PRODUCTS 149
TABLE 48 CODMAN CATHETER PRODUCTS 149
COLOPLAST A/S 150
BUSINESS OVERVIEW 150
PRODUCTS 150
HLC019G - Global Markets for Catheters

TABLE 49 COLOPLAST CATHETER PRODUCTS 150
FINANCIAL SUMMARY 150
TABLE 50 COLOPLAST FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 151
COOK MEDICAL INC. 151
BUSINESS OVERVIEW 151
PRODUCTS 152
TABLE 51 COOK MEDICAL CATHETER PRODUCTS 152
C. R. BARD 153
BUSINESS OVERVIEW 153
PRODUCTS 154
TABLE 52 C. R. BARD CATHETER PRODUCTS 154
FINANCIAL SUMMARY 155
TABLE 53 C. R. BARD FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 155
EDWARDS LIFESCIENCES CORP. 155
BUSINESS OVERVIEW 155
PRODUCTS 156
TABLE 54 EDWARDS LIFESCIENCES CATHETER PRODUCTS 156
FINANCIAL SUMMARY 156
TABLE 55 EDWARDS LIFESCIENCES FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 157
FLEXICATH LTD 157
BUSINESS OVERVIEW 157
PRODUCTS 157
TABLE 56 FLEXICATH CATHETER PRODUCTS 157
GOODMAN CO. LTD. 158
BUSINESS OVERVIEW 158
PRODUCTS 158
TABLE 57 GOODMAN CATHETER PRODUCTS 158
HOLLISTER INC. 158
BUSINESS OVERVIEW 159
PRODUCTS 159
TABLE 58 HOLLISTER CATHETER PRODUCTS 159
ICU MEDICAL INC. 159
BUSINESS OVERVIEW 159
PRODUCTS 160
TABLE 59 ICU MEDICAL CATHETER PRODUCTS 160
FINANCIAL SUMMARY 160
TABLE 60 ICU MEDICAL FINANCIAL SUMMARY, 2013-2015* ($ THOUSANDS) 160
INTEGRA LIFESCIENCES 160
BUSINESS OVERVIEW 161
PRODUCTS 161
TABLE 61 INTEGRA LIFESCIENCES CATHETER PRODUCTS 161
FINANCIAL SUMMARY 161
TABLE 62 INTEGRA LIFESCIENCES FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 161
JOHNSON and JOHNSON 161
BUSINESS OVERVIEW 162
PRODUCTS 162
TABLE 63 JOHNSON and JOHNSON CATHETER PRODUCTS 162

FINANCIAL SUMMARY 162
TABLE 64 JOHNSON and JOHNSON FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 163
RECENT ACTIVITY 163
MANFRED SAUER GMBH 163
BUSINESS OVERVIEW 163
PRODUCTS 164
TABLE 65 MANFRED SAUER CATHETER PRODUCTS 164
MAQUET GETINGE GROUP 164
BUSINESS OVERVIEW 164
PRODUCTS 165
TABLE 66 MAQUET GETINGE CATHETER PRODUCTS 165
MEDICAL COMPONENTS INC. 165
BUSINESS OVERVIEW 165
PRODUCTS 166
TABLE 67 MEDICAL COMPONENTS CATHETER PRODUCTS 166
MEDLINE INDUSTRIES INC. 166
BUSINESS OVERVIEW 167
PRODUCTS 167
TABLE 68 MEDLINE CATHETER PRODUCTS 167
MEDTRONIC 167
BUSINESS OVERVIEW 167
PRODUCTS 168
TABLE 69 MEDTRONIC CATHETER PRODUCTS 168
FINANCIAL SUMMARY 169
TABLE 70 MEDTRONIC FINANCIAL SUMMARY 2013-2015* ($ MILLIONS) 169
RECENT ACTIVITY 170
MERIT MEDICAL SYSTEMS INC. 170
BUSINESS OVERVIEW 170
PRODUCTS 170
TABLE 71 MERIT MEDICAL SYSTEMS CATHETER PRODUCTS 170
FINANCIAL SUMMARY 171
TABLE 72 MERIT MEDICAL SYSTEMS FINANCIAL SUMMARY, 2013-2015* ($
MILLIONS) 171
MICROPORT SCIENTIFIC CORP. 171
BUSINESS OVERVIEW 172
PRODUCTS 172
TABLE 73 MICROPORT SCIENTIFIC CATHETER PRODUCTS 172
PULSION MEDICAL SYSTEMS SE 172
BUSINESS OVERVIEW 172
PRODUCTS 173
TABLE 74 PULSION MEDICAL SYSTEMS CATHETER PRODUCTS 173
SANOVAS INC. 173
BUSINESS OVERVIEW 173
PRODUCTS 173
TABLE 75 SANOVAS CATHETER PRODUCTS 173
SIEMENS MEDICAL SOLUTIONS USA INC. 174
BUSINESS OVERVIEW 174
PRODUCTS 174
HLC019G - Global Markets for Catheters

TABLE 76 SIEMENS CATHETER PRODUCTS 174
FINANCIAL SUMMARY 174
TABLE 77 SIEMENS FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 174
SMITHS GROUP PLC 175
BUSINESS OVERVIEW 175
PRODUCTS 175
TABLE 78 SMITHS MEDICAL CATHETER PRODUCTS 175
FINANCIAL SUMMARY 176
TABLE 79 SMITHS GROUP FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 176
SPECTRANETICS 176
BUSINESS OVERVIEW 176
PRODUCTS 177
TABLE 80 SPECTRANETICS CATHETER PRODUCTS 177
FINANCIAL SUMMARY 177
TABLE 81 SPECTRANETICS FINANCIAL SUMMARY, 2013-2015* ($ THOUSANDS) 177
BUSINESS ACTIVITIES 178
ST. JUDE MEDICAL 178
BUSINESS OVERVIEW 178
PRODUCTS 179
TABLE 82 ST. JUDE MEDICAL CATHETER PRODUCTS 179
FINANCIAL SUMMARY 179
TABLE 83 ST. JUDE MEDICAL FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 179
STRAUB MEDICAL AG 180
BUSINESS OVERVIEW 180
PRODUCTS 180
TABLE 84 STRAUB MEDICAL AG CATHETER PRODUCTS 180
STRYKER 180
BUSINESS OVERVIEW 181
PRODUCTS 181
TABLE 85 STRYKER CATHETER PRODUCTS 181
FINANCIAL SUMMARY 181
TABLE 86 STRYKER FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 181
TELEFLEX INC. 182
BUSINESS OVERVIEW 182
PRODUCTS 182
TABLE 87 TELEFLEX CATHETER PRODUCTS 182
FINANCIAL SUMMARY 183
TABLE 88 TELEFLEX FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 183
TERUMO CORP. 183
BUSINESS OVERVIEW 184
PRODUCTS 184
TABLE 89 TERUMO CATHETER PRODUCTS 184
FINANCIAL SUMMARY 184
TABLE 90 TERUMO FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 185
VASCULAR SOLUTIONS INC. 185
BUSINESS OVERVIEW 185
PRODUCTS 186

TABLE 91 VASCULAR SOLUTIONS CATHETER PRODUCTS 186
FINANCIAL SUMMARY 186
TABLE 92 VASCULAR SOLUTIONS FINANCIAL SUMMARY, 2013-2015* ($
THOUSANDS) 187
VOLCANO CORP. 187
BUSINESS OVERVIEW 187
PRODUCTS 188
TABLE 93 VOLCANO CORP. CATHETER PRODUCTS 188
HLC019G - Global Markets for Catheters

LIST OF TABLES

SUMMARY TABLE GLOBAL MARKET FOR CATHETERS BY SEGMENT, THROUGH 2021
($ MILLIONS) 7
TABLE 1 INDICATIONS FOR CARDIAC CATHETERIZATION 11
TABLE 2 TYPES OF CARDIAC CATHETERS 12
TABLE 3 PCI PROCEDURES 14
TABLE 4 COMPLICATIONS DUE TO IV CATHETERS 21
TABLE 5 HEALTHCARE EXPENDITURE AS A PERCENTAGE OF GDP BY COUNTRY,
2008-2014* (%) 30
TABLE 6 LIFE EXPECTANCY DATA AND PROJECTIONS, 1970-2015 32
TABLE 7 ESTIMATES OF THE TOP 10 COUNTRIES WITH HIGHEST LIFE EXPECTANCY
AT AGE 65, 2015 (%) 32
TABLE 8 BIRTH RATES FOR SELECTED COUNTRIES, 2014 (%) 33
TABLE 9 PERCENTAGE OF POPULATION AGE 65 AND OLDER IN SELECTED
COUNTRIES, 2014 (MILLIONS/%) 34
TABLE 10 NUMBER OF CORONARY ANGIOPLASTY PROCEDURES BY SELECTED
COUNTRY, 2005-2015* (PER 100,000 POPULATIONS) 35
TABLE 11 PREVALENCE OF CANCER BY SELECTED COUNTRY, 2012* (PER 100,000
POPULATION) 36
TABLE 12 CHARACTERISTICS OF CATHETER MATERIALS 41
TABLE 13 ADVANTAGES AND DISADVANTAGES OF CATHETER MATERIALS 49
TABLE 14 GLOBAL MARKET FOR CATHETERS BY TYPE, THROUGH 2021 ($ MILLIONS) 52
TABLE 15 GLOBAL MARKET FOR CARDIOVASCULAR CATHETERS BY TYPE, THROUGH
2021 ($ MILLIONS) 59
TABLE 16 GLOBAL MARKET FOR EP CARDIOVASCULAR CATHETERS BY USE,
THROUGH 2021 ($ MILLIONS) 61
TABLE 17 GLOBAL MARKET FOR UROLOGICAL CATHETERS BY TYPE, THROUGH 2021
($ MILLIONS) 67
TABLE 18 GLOBAL MARKET FOR INTERMITTENT UROLOGICAL CATHETERS BY USE,
THROUGH 2021 ($ MILLIONS) 68
TABLE 19 GLOBAL MARKET FOR INTRAVENOUS CATHETERS BY TYPE, THROUGH
2021 ($ MILLIONS) 73
TABLE 20 GLOBAL MARKET FOR CENTRAL VENOUS CATHETERS BY USE, THROUGH
2021 ($ MILLIONS) 74
TABLE 21 GLOBAL MARKET FOR NEUROVASCULAR CATHETERS, THROUGH 2021 ($
MILLIONS) 79
TABLE 22 GLOBAL MARKET FOR SPECIALTY CATHETERS BY TYPE, THROUGH 2021 ($
MILLIONS) 83
TABLE 23 GLOBAL MARKET FOR CATHETERS BY REGION, THROUGH 2021 ($
MILLIONS) 87
TABLE 24 U.S. MARKET FOR CATHETERS BY TYPE, THROUGH 2021 ($ MILLIONS) 92
TABLE 25 U.S. RATES OF CARDIOVASCULAR PROCEDURES, 2007-2010 (THOUSANDS) 94
TABLE 26 EUROPEAN MARKET FOR CATHETERS BY TYPE, THROUGH 2021 ($
MILLIONS) 101
TABLE 27 ASIAN MARKET FOR CATHETERS BY TYPE, THROUGH 2021 ($ MILLIONS) 108
TABLE 28 USPTO CATHETER PATENT ACTIVITY BY ASSIGNEE, LAST 100 PATENTS
THROUGH FEBRUARY 2016 (NO.) 113
TABLE 29 USPTO CATHETER PATENTS ISSUED BY YEAR, 2005-2015 (NO.) 114
TABLE 30 USPTO CATHETER PATENTS ISSUED BY TYPE, 2015 (NO.) 115
TABLE 31 RECENT CATHETER PATENTS, DECEMBER 2015 116
HLC019G - Global Markets for Catheters

TABLE 32 GLOBAL CATHETER MARKET SHARES OF LEADING MANUFACTURERS,
2015 (%) 134
TABLE 33 MERGERS/ACQUISITIONS IN THE GLOBAL CATHETER MARKET, 2010-2015 135
TABLE 34 ABBOTT LABORATORIES CATHETER PRODUCTS 136
TABLE 35 ABBOTT LABORATORIES FINANCIAL SUMMARY, 2013-2015* 137
TABLE 36 ANGIODYNAMICS CATHETER PRODUCTS 137
TABLE 37 ANGIODYNAMICS FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 138
TABLE 38 ARGON MEDICAL CATHETER PRODUCTS 139
TABLE 39 B. BRAUN CATHETER PRODUCTS 140
TABLE 40 B. BRAUN FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 141
TABLE 41 BECTON DICKINSON CATHETER PRODUCTS 142
TABLE 42 BECTON DICKINSON FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 142
TABLE 43 BOSTON SCIENTIFIC CATHETER PRODUCTS 143
TABLE 44 BOSTON SCIENTIFIC FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 146
TABLE 45 CARDINAL HEALTH (CORDIS) CATHETER PRODUCTS 147
TABLE 46 CARDINAL HEALTH FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 147
TABLE 47 CARDIOMED CATHETER PRODUCTS 148
TABLE 48 CODMAN CATHETER PRODUCTS 149
TABLE 49 COLOPLAST CATHETER PRODUCTS 150
TABLE 50 COLOPLAST FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 151
TABLE 51 COOK MEDICAL CATHETER PRODUCTS 152
TABLE 52 C. R. BARD CATHETER PRODUCTS 154
TABLE 53 C. R. BARD FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 155
TABLE 54 EDWARDS LIFESCIENCES CATHETER PRODUCTS 156
TABLE 55 EDWARDS LIFESCIENCES FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 157
TABLE 56 FLEXICATH CATHETER PRODUCTS 157
TABLE 57 GOODMAN CATHETER PRODUCTS 158
TABLE 58 HOLLISTER CATHETER PRODUCTS 159
TABLE 59 ICU MEDICAL CATHETER PRODUCTS 160
TABLE 60 ICU MEDICAL FINANCIAL SUMMARY, 2013-2015* ($ THOUSANDS) 160
TABLE 61 INTEGRA LIFESCIENCES CATHETER PRODUCTS 161
TABLE 62 INTEGRA LIFESCIENCES FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 161
TABLE 63 JOHNSON and JOHNSON CATHETER PRODUCTS 162
TABLE 64 JOHNSON and JOHNSON FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 163
TABLE 65 MANFRED SAUER CATHETER PRODUCTS 164
TABLE 66 MAQUET GETINGE CATHETER PRODUCTS 165
TABLE 67 MEDICAL COMPONENTS CATHETER PRODUCTS 166
TABLE 68 MEDLINE CATHETER PRODUCTS 167
TABLE 69 MEDTRONIC CATHETER PRODUCTS 168
TABLE 70 MEDTRONIC FINANCIAL SUMMARY 2013-2015* ($ MILLIONS) 169
TABLE 71 MERIT MEDICAL SYSTEMS CATHETER PRODUCTS 170
TABLE 72 MERIT MEDICAL SYSTEMS FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 171
TABLE 73 MICROPORT SCIENTIFIC CATHETER PRODUCTS 172
TABLE 74 PULSION MEDICAL SYSTEMS CATHETER PRODUCTS 173
TABLE 75 SANOVAS CATHETER PRODUCTS 173
TABLE 76 SIEMENS CATHETER PRODUCTS 174
TABLE 77 SIEMENS FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 174
TABLE 78 SMITHS MEDICAL CATHETER PRODUCTS 175

TABLE 79 SMITHS GROUP FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 176
TABLE 80 SPECTRANETICS CATHETER PRODUCTS 177
TABLE 81 SPECTRANETICS FINANCIAL SUMMARY, 2013-2015* ($ THOUSANDS) 177
TABLE 82 ST. JUDE MEDICAL CATHETER PRODUCTS 179
TABLE 83 ST. JUDE MEDICAL FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 179
TABLE 84 STRAUB MEDICAL AG CATHETER PRODUCTS 180
TABLE 85 STRYKER CATHETER PRODUCTS 181
TABLE 86 STRYKER FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 181
TABLE 87 TELEFLEX CATHETER PRODUCTS 182
TABLE 88 TELEFLEX FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 183
TABLE 89 TERUMO CATHETER PRODUCTS 184
TABLE 90 TERUMO FINANCIAL SUMMARY, 2013-2015* ($ MILLIONS) 185
TABLE 91 VASCULAR SOLUTIONS CATHETER PRODUCTS 186
TABLE 92 VASCULAR SOLUTIONS FINANCIAL SUMMARY, 2013-2015* ($ THOUSANDS) 187
TABLE 93 VOLCANO CORP. CATHETER PRODUCTS 188


LIST OF FIGURES

SUMMARY FIGURE GLOBAL MARKET FOR CATHETERS BY SEGMENT, 2014-2021 ($
MILLIONS) 7
FIGURE 1 FACTORS INFLUENCING THE MEDICAL DEVICE MARKET 29
FIGURE 2 GLOBAL MARKET FOR CATHETERS BY TYPE, 2014-2021 ($ MILLIONS) 52
FIGURE 3 GLOBAL MARKET SHARES OF CATHETERS BY TYPE, 2015 AND 2021 (%) 54
FIGURE 4 GLOBAL MARKET FOR CARDIOVASCULAR CATHETERS BY TYPE, 2014-2021
($ MILLIONS) 59
FIGURE 5 GLOBAL MARKET SHARES OF EP CARDIOVASCULAR CATHETERS BY USE,
2015 (%) 61
FIGURE 6 GLOBAL MANUFACTURER MARKET SHARES OF ALL TYPES OF CARDIAC
CATHETERS, 2015 (%) 63
FIGURE 7 GLOBAL MARKET FOR UROLOGICAL CATHETERS BY TYPE, 2014-2021 ($
MILLIONS) 67
FIGURE 8 GLOBAL MARKET SHARES OF INTERMITTENT UROLOGICAL CATHETERS BY
USE, 2015 (%) 68
FIGURE 9 GLOBAL MARKET SHARES OF UROLOGICAL CATHETERS BY COMPANY,
2015 (%) 70
FIGURE 10 GLOBAL MARKET FOR INTRAVENOUS CATHETERS BY TYPE, 2014-2021 ($
MILLIONS) 73
FIGURE 11 GLOBAL MARKET SHARES OF CENTRAL VENOUS CATHETERS BY USE,
2015 (%) 74
FIGURE 12 GLOBAL MARKET SHARES OF IV CATHETERS BY COMPANY, 2015 (%) 76
FIGURE 13 GLOBAL MARKET FOR NEUROVASCULAR CATHETERS, 2014-2021 ($
MILLIONS) 79
FIGURE 14 GLOBAL MARKET SHARES OF NEUROVASCULAR CATHETERS BY
COMPANY, 2015 (%) 80
FIGURE 15 GLOBAL MARKET FOR SPECIALTY CATHETERS BY TYPE, 2014-2021 ($
MILLIONS) 84
FIGURE 16 GLOBAL MARKET SHARES OF SPECIALTY CATHETERS BY TYPE, 2015 (%) 84
FIGURE 17 GLOBAL MARKET SHARES OF SPECIALTY CATHETERS BY COMPANY, 2015
(%) 86
FIGURE 18 GLOBAL MARKET SHARES OF CATHETERS BY REGION, 2015 AND 2021
(%) 88
FIGURE 19 U.S. MARKET FOR CATHETERS BY TYPE, 2014-2021 ($ MILLIONS) 92
FIGURE 20 LEADING CAUSES OF DEATH FOR MEN AND WOMEN UNDER THE AGE OF
75 IN THE EU (%) 98
FIGURE 21 EUROPEAN MARKET FOR CATHETERS BY TYPE, 2014-2021 ($ MILLIONS) 101
FIGURE 22 ASIAN MARKET FOR CATHETERS BY TYPE, 2014-2021 ($ MILLIONS) 108
FIGURE 23 USPTO CATHETER PATENTS ISSUED BY YEAR, 2005-2015 (NO.) 114
FIGURE 24 USPTO CATHETER PATENTS ISSUED BY TYPE, 2015 (NO.) 116

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Ophthalmology Devices Market - Market Share Analysis & Global Forecasts to 2021

Ophthalmology Devices Market - Market Share Analysis & Global Forecasts to 2021

  • $ 7 150
  • Industry report
  • May 2016
  • by MarketsandMarkets

The global ophthalmology devices market is projected to reach USD 58.05 billion by 2021, at a CAGR of 3.7% during the forecast period of 2016 to 2021. The growth in this market is majorly driven by the ...

Contact Lenses: Technologies and Global Markets

Contact Lenses: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • June 2016
  • by BCC Research

This BCC Research report explores present and future strategies within the contact lens market, which includes soft contact lenses, rigid gas permeable lenses and other lenses such as hybrid lenses, advanced ...

Epiomic Epidemiology Series: Malignant Melanoma Forecast in 20 Major Markets 2016-2026

Epiomic Epidemiology Series: Malignant Melanoma Forecast in 20 Major Markets 2016-2026

  • $ 6 172
  • Industry report
  • June 2016
  • by Black Swan Analysis Ltd

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Malignant Melanoma in 20 Major Markets Cutaneous Malignant Melanoma is a form of cancer of the skin arising from melanocytes on the ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.